Skip to main content
Top
Published in: Clinical Rheumatology 1/2008

01-01-2008 | Case Report

Magic syndrome and true aortic aneurysm

Authors: C. Hidalgo-Tenorio, J. M. Sabio-Sánchez, P. J. P. Linares, L. M. Salmerón, E. Ros-Die, J. Jiménez-Alonso

Published in: Clinical Rheumatology | Issue 1/2008

Login to get access

Abstract

Magic syndrome is a very uncommon disease, and vascular involvement is exceptional; only one case has been reported in the literature associated to a true aortic aneurysm. The treatment of aneurysms recommended in these patients is based on isolated cases and includes corticosteroids, other immunosuppressant drugs, and surgery. We report a case of a patient with Magic syndrome who developed aneurysm at the end of the aorta during treatment with infliximab, corticosteroids, and cyclosporine and who needed endovascular prosthesis implantation. After 12 months, she suffered an aneurysm of the ascending aorta, dilatation of the sinotubular junction, and severe aortic insufficiency, which forced surgery. During this time, the patient finally died.
Literature
1.
go back to reference Gertner E (2004) Severe recurrent neurological disease in the MAGIC syndrome. J Rheumatol 31:1018–1019PubMed Gertner E (2004) Severe recurrent neurological disease in the MAGIC syndrome. J Rheumatol 31:1018–1019PubMed
2.
go back to reference Fernandez-Monras F, Fornos C, Argimon J (1997) Aneurisma aórtico en el síndrome de MAGIC. Med Clin (Barc) 109:684–685 Fernandez-Monras F, Fornos C, Argimon J (1997) Aneurisma aórtico en el síndrome de MAGIC. Med Clin (Barc) 109:684–685
3.
go back to reference Caceres M, Estrera AL, Buja LM, Safi HJ (2006) Transverse aortic arch replacement associated with MAGIC syndrome: case report and literature review. Ann Vasc Surg 20:395–398PubMedCrossRef Caceres M, Estrera AL, Buja LM, Safi HJ (2006) Transverse aortic arch replacement associated with MAGIC syndrome: case report and literature review. Ann Vasc Surg 20:395–398PubMedCrossRef
4.
go back to reference Watanabe H, Oda H, Yoshida T, Yamaura M, Takahashi K, Miida T et al (2005) Endovascular stent-grafting for recurrent aneurysm in Behcet’s disease. Int Heart J 46:745–749PubMedCrossRef Watanabe H, Oda H, Yoshida T, Yamaura M, Takahashi K, Miida T et al (2005) Endovascular stent-grafting for recurrent aneurysm in Behcet’s disease. Int Heart J 46:745–749PubMedCrossRef
5.
go back to reference Goueffic Y, Pistorius MA, Heymann MF, Chaillou P, Patra P (2005) Association of aneurysmal and occlusive lesions in Behcet’s disease. Ann Vasc Surg 19:276–279PubMedCrossRef Goueffic Y, Pistorius MA, Heymann MF, Chaillou P, Patra P (2005) Association of aneurysmal and occlusive lesions in Behcet’s disease. Ann Vasc Surg 19:276–279PubMedCrossRef
6.
go back to reference Barretto SN, Oliveira GH, Michet CJ Jr, Nyman MA, Edwards WD, Kullo IJ (2002) Multiple cardiovascular complications in a patient with relapsing polychondritis. Mayo Clin Proc 77:971–974PubMedCrossRef Barretto SN, Oliveira GH, Michet CJ Jr, Nyman MA, Edwards WD, Kullo IJ (2002) Multiple cardiovascular complications in a patient with relapsing polychondritis. Mayo Clin Proc 77:971–974PubMedCrossRef
7.
go back to reference Iscan ZH, Vural KM, Bayazit MJ (2005) Compelling nature of arterial manifestations in Behcet disease. Vasc Surg 41:53–58CrossRef Iscan ZH, Vural KM, Bayazit MJ (2005) Compelling nature of arterial manifestations in Behcet disease. Vasc Surg 41:53–58CrossRef
8.
go back to reference Le Thi Huong D, Wechsler B, Papo T et al (1995) Arterial lesions in Behçet’s disease. A study in 25 patients. J Rheumatol 22:2103–13.6PubMed Le Thi Huong D, Wechsler B, Papo T et al (1995) Arterial lesions in Behçet’s disease. A study in 25 patients. J Rheumatol 22:2103–13.6PubMed
9.
go back to reference Nitecki SS, Ofer A, Karran T, Schwartz H, Engel A, Hoffman A (2004) Abdominal aortic aneurysm in Behçet’s disease: new treatment options for an old and challenging problem. Isr Med Assoc J 6:152–155PubMed Nitecki SS, Ofer A, Karran T, Schwartz H, Engel A, Hoffman A (2004) Abdominal aortic aneurysm in Behçet’s disease: new treatment options for an old and challenging problem. Isr Med Assoc J 6:152–155PubMed
Metadata
Title
Magic syndrome and true aortic aneurysm
Authors
C. Hidalgo-Tenorio
J. M. Sabio-Sánchez
P. J. P. Linares
L. M. Salmerón
E. Ros-Die
J. Jiménez-Alonso
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0688-9

Other articles of this Issue 1/2008

Clinical Rheumatology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine